Delivery Order SPE2DB20D2104-SPE2DB25FMYEB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) with a ceiling value of $7,213.88. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,710.30 for Vemlidy 25 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $2,981.76 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 22, 2025, with a completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $134,109.38 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract calls for performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a contract ceiling value of $5,094.43. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement through open competition. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $3,914.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a non-set-aside competitive award representing a child order under AmerisourceBergen's larger contract vehicle with DLA. Vemlidy is an antiviral medication, and this delivery order reflects AmerisourceBergen's role as a critical pharmaceutical supplier supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a firm fixed price of $9,521.05 and an ultimate completion date of August 19, 2025. This is a non-set-aside, competitively awarded contract with performance to be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,198.80, is for the supply of Vemlidy 25 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 18, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This firm fixed-price contract, valued at $15,138.05, represents a competitive award with no set-aside designation and an ultimate completion date of July 21, 2025. The award is classified as a child contract, indicating it derives from a larger prime contract vehicle. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This contract, valued at $5,494.42, represents a firm fixed-price delivery order with an ultimate completion date of August 22, 2025. The award was made without a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYEBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count unit) under a firm fixed-price contract with a ceiling value of $2,870.64. The award, made on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This non-set-aside, competitively awarded contract leverages AmerisourceBergen's established position as a critical pharmaceutical distributor for federal medical procurement, particularly serving military and veteran healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, holds a comprehensive $1 billion IDC vehicle (SPE2DX) through December 2026 that enables the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's contract portfolio demonstrates extensive experience fulfilling federal medical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and vaccines. The DLA Troop Support Medical supply chain relationship positions AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible procurement vehicles as part of the broader Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/19/25 |